BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7734404)

  • 21. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
    Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
    Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
    Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
    Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate.
    Span PN; Schalken JA; Sweep FG; Smals AG
    Prostate; 1998 Feb; 34(3):222-30. PubMed ID: 9492851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5 alpha-reductase inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H; Tunn S; Debus M; Krieg M
    Steroids; 1994 Nov; 59(11):616-20. PubMed ID: 7535480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
    Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
    Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H; Krieg M
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):49-55. PubMed ID: 9780029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo assay for conversion of testosterone to dihydrotestosterone by rat prostatic steroid 5 alpha-reductase and comparison of two inhibitors.
    Toomey RE; Goode RL; Petrow V; Neubauer BL
    Prostate; 1991; 19(1):63-72. PubMed ID: 1876537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
    Di Salle E; Briatico G; Giudici D; Ornati G; Panzeri A
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning, expression and functional characterization of type 1 and type 2 steroid 5 alpha-reductases from Cynomolgus monkey: comparisons with human and rat isoenzymes.
    Levy MA; Brandt M; Sheedy KM; Holt DA; Heaslip JI; Trill JJ; Ryan PJ; Morris RA; Garrison LM; Bergsma DJ
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):307-19. PubMed ID: 7734398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta).
    Prahalada S; Tarantal AF; Harris GS; Ellsworth KP; Clarke AP; Skiles GL; MacKenzie KI; Kruk LF; Ablin DS; Cukierski MA; Peter CP; vanZwieten MJ; Hendrickx AG
    Teratology; 1997 Feb; 55(2):119-31. PubMed ID: 9143092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel class of inhibitors for human steroid 5alpha-reductase: synthesis and biological evaluation of indole derivatives. II.
    Igarashi S; Inami H; Hara H; Fujii M; Koutoku H; Oritani H; Mase T
    Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):382-8. PubMed ID: 10726862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
    Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue distribution kinetics of a new nonsteroidal 5 alpha-reductase [correction of 5 A-reductase] inhibitor, 4-[3-[3-[bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-YL ]-butyric acid, in rats.
    Katashima M; Yamamoto K; Haraguchi K; Tokuma Y; Hata T; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Sep; 25(9):1051-8. PubMed ID: 9311620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-(Benzoylindolizinyl)butyric acids; novel nonsteroidal inhibitors of steroid 5alpha-reductase. III.
    Sawada K; Okada S; Kuroda A; Watanabe S; Sawada Y; Tanaka H
    Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):799-813. PubMed ID: 11456083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors.
    Laroque PA; Prahalada S; Molon-Noblot S; Cohen SM; Soper K; Duprat P; Peter CP; van Zwieten MJ
    Prostate; 1995 Sep; 27(3):121-8. PubMed ID: 7567690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
    Berthaut I; Mestayer C; Portois MC; Cussenot O; Mowszowicz I
    Prostate; 1997 Aug; 32(3):155-63. PubMed ID: 9254894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A putative 5 alpha-reductase inhibitor demasculinizes portions of the zebra finch song system.
    Grisham W; Tam A; Greco CM; Schlinger BA; Arnold AP
    Brain Res; 1997 Mar; 750(1-2):122-8. PubMed ID: 9098536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II.
    Pais P
    Adv Ther; 2010 Aug; 27(8):555-63. PubMed ID: 20623347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chlormadinone acetate and ethinylestradiol treatment on epididymal 5 alpha-reductase activities in patients with prostate cancer.
    Nukui F
    Endocr J; 1997 Feb; 44(1):127-32. PubMed ID: 9152625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.